QQQ   427.77 (+0.45%)
AAPL   168.14 (+0.08%)
MSFT   411.11 (-0.18%)
META   510.32 (+3.27%)
GOOGL   156.25 (+0.50%)
AMZN   182.25 (+0.54%)
TSLA   151.69 (-2.42%)
NVDA   855.17 (+1.76%)
AMD   156.18 (+1.40%)
NIO   4.07 (+4.09%)
BABA   69.54 (+1.05%)
T   16.18 (+0.37%)
F   12.14 (+0.83%)
MU   115.47 (-0.74%)
GE   156.85 (+0.76%)
CGC   7.87 (+21.26%)
DIS   114.06 (+0.99%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.95 (-0.49%)
XOM   119.14 (+0.43%)
QQQ   427.77 (+0.45%)
AAPL   168.14 (+0.08%)
MSFT   411.11 (-0.18%)
META   510.32 (+3.27%)
GOOGL   156.25 (+0.50%)
AMZN   182.25 (+0.54%)
TSLA   151.69 (-2.42%)
NVDA   855.17 (+1.76%)
AMD   156.18 (+1.40%)
NIO   4.07 (+4.09%)
BABA   69.54 (+1.05%)
T   16.18 (+0.37%)
F   12.14 (+0.83%)
MU   115.47 (-0.74%)
GE   156.85 (+0.76%)
CGC   7.87 (+21.26%)
DIS   114.06 (+0.99%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.95 (-0.49%)
XOM   119.14 (+0.43%)
QQQ   427.77 (+0.45%)
AAPL   168.14 (+0.08%)
MSFT   411.11 (-0.18%)
META   510.32 (+3.27%)
GOOGL   156.25 (+0.50%)
AMZN   182.25 (+0.54%)
TSLA   151.69 (-2.42%)
NVDA   855.17 (+1.76%)
AMD   156.18 (+1.40%)
NIO   4.07 (+4.09%)
BABA   69.54 (+1.05%)
T   16.18 (+0.37%)
F   12.14 (+0.83%)
MU   115.47 (-0.74%)
GE   156.85 (+0.76%)
CGC   7.87 (+21.26%)
DIS   114.06 (+0.99%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.95 (-0.49%)
XOM   119.14 (+0.43%)
QQQ   427.77 (+0.45%)
AAPL   168.14 (+0.08%)
MSFT   411.11 (-0.18%)
META   510.32 (+3.27%)
GOOGL   156.25 (+0.50%)
AMZN   182.25 (+0.54%)
TSLA   151.69 (-2.42%)
NVDA   855.17 (+1.76%)
AMD   156.18 (+1.40%)
NIO   4.07 (+4.09%)
BABA   69.54 (+1.05%)
T   16.18 (+0.37%)
F   12.14 (+0.83%)
MU   115.47 (-0.74%)
GE   156.85 (+0.76%)
CGC   7.87 (+21.26%)
DIS   114.06 (+0.99%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.95 (-0.49%)
XOM   119.14 (+0.43%)
Free Trial
TSE:I

Intellipharmaceutics International (I) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free I Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$3.23
▼
C$3.23
52-Week Range
N/A
Volume
7,625 shs
Average Volume
16,872 shs
Market Capitalization
C$97.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Intellipharmaceutics International

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

I Stock News Headlines

February 19, 2024 | theglobeandmail.com
IntelliPharmaCeutics Intl: Top 10 Undervalued Biotechnology Industry Stocks (IPCI)
January 3, 2024 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc up on Wednesday (IPCI)
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
December 7, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc up on Tuesday (IPCI)
October 16, 2023 | msn.com
Intellipharmaceutics International GAAP EPS of -$0.06
October 13, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc down on Friday (IPCI)
July 6, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc down on Wednesday (IPCI)
June 29, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc down on Tuesday (IPCI)
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
June 13, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc down on Monday (IPCI)
April 18, 2023 | finance.yahoo.com
Intellipharmaceutics International Inc. (I4AA.F)
April 7, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc flat on Wednesday (IPCI)
April 5, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc flat on Monday (IPCI)
April 4, 2023 | theglobeandmail.com
Closing Bell: Intellipharmaceutics International Inc flat on Friday (IPCI)
February 7, 2023 | yahoo.com
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order
January 13, 2023 | finance.yahoo.com
Intellipharmaceutics International Inc. (IPCIF)
August 30, 2022 | thestreet.com
Changes at the Top for Endo Could Benefit Its Smaller Partners
August 23, 2022 | reuters.com
Intellipharmaceutics International Inc
July 23, 2022 | finanznachrichten.de
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2022 Results
July 21, 2022 | finance.yahoo.com
Intellipharmaceutics Announces Second Quarter 2022 Results
July 15, 2022 | ca.finance.yahoo.com
Stocks in play: Intellipharmaceutics International Inc.
April 14, 2022 | finanznachrichten.de
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2022 Results
April 14, 2022 | stockhouse.com
Intellipharmaceutics Announces First Quarter 2022 Results
February 28, 2022 | finanznachrichten.de
Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Fiscal Year 2021 Results
January 13, 2022 | finanznachrichten.de
Intellipharmaceutics International Inc.: Intellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene Keirstead
January 7, 2022 | nasdaq.com
Intellipharmaceutics International Inc (IPCIF)
October 15, 2021 | finance.yahoo.com
Intellipharmaceutics Announces Third Quarter 2021 Results
See More Headlines
Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Next Earnings (Estimated)
6/04/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Business Services
Industry
Wireless Telecommunications
Sub-Industry
N/A
Current Symbol
TSE:I
CUSIP
N/A
CIK
N/A
Web
www.intelsat.com
Phone
+1-416-7983001
Fax
N/A
Employees
1,195
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
30,156,000
Free Float
N/A
Market Cap
C$97.40 million
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Isa Odidi Ph.D.
    Chairman of the Board, Chief Executive Officer
  • Amina Odidi Ph.D.
    President, Chief Operating Officer, Director
  • Andrew Patient
    Chief Financial Officer
  • John N. Allport
    Vice President - Legal Affairs and Licensing, Secretary, Director
  • Patrick N. Yat Ph.D.
    Vice President - Pharmaceutical Analysis and Chemistry
  • Kenneth Keirstead
    Independent Director
  • Bahadur Madhani
    Independent Director
  • Eldon R. Smith M.D. (Age 75)
    Independent Director

Key Competitors

View All Competitors

I Stock Analysis - Frequently Asked Questions

When is Intellipharmaceutics International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our I earnings forecast.

What other stocks do shareholders of Intellipharmaceutics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellipharmaceutics International investors own include QuickLogic (QUIK), VBI Vaccines (VBIV), NeuLion (NLN), Micron Technology (MU), Mallinckrodt (MNK), Intellipharmaceutics International (IPCIF), Fitbit (FIT), Clean Commodities (CLE), Calithera Biosciences (CALA) and BlackBerry (BB).

How do I buy shares of Intellipharmaceutics International?

Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:I) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Your Money is Not Safe
American Alternative
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Options trading has suddenly become more reliable.
Eagle Publishing